Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Conaghan

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Osteoarthritis and Cartilage|March 23, 2019
Corticosteroids and osteoarthritis progression: a confounded issueP G Conaghan
British Journal of Sports Medicine|September 28, 2002
Update on osteoarthritis part 1: current concepts and the relation to exerciseP G Conaghan
Current Opinion in Rheumatology|May 1, 1996
Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamineP G Conaghan, P Brooks
Annals of the Rheumatic Diseases|October 30, 2003
Cyclosporin and methotrexate therapyP G Conaghan, P Emery
Current Opinion in Rheumatology|May 1, 1993
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and D-penicillamineP G Conaghan, P Brooks
Current Opinion in Rheumatology|May 1, 1995
Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamineP G Conaghan, P Brooks
Scandinavian Journal of Rheumatology|August 29, 2025
Understanding the use of thermography and its ability to predict ultrasound-detected joint inflammation at the metacarpophalangeal joint in patients with rheumatoid arthritisY K Tan, P G Conaghan
Current Opinion in Rheumatology|January 1, 1994
Rheumatic manifestations of malignancyP G Conaghan, P M Brooks
Drug Safety|October 1, 1994
Risks and benefits of drugs used in the management and prevention of goutP G Conaghan, R O Day
Arthritis and Rheumatism|June 12, 1999
Psoriatic arthritis: a unified concept twenty years onD McGonagle, P G Conaghan, P Emery
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Osteoarthritis and Cartilage|March 23, 2019
Corticosteroids and osteoarthritis progression: a confounded issueP G Conaghan
British Journal of Sports Medicine|September 28, 2002
Update on osteoarthritis part 1: current concepts and the relation to exerciseP G Conaghan
Current Opinion in Rheumatology|May 1, 1996
Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamineP G Conaghan, P Brooks
Annals of the Rheumatic Diseases|October 30, 2003
Cyclosporin and methotrexate therapyP G Conaghan, P Emery
Current Opinion in Rheumatology|May 1, 1993
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and D-penicillamineP G Conaghan, P Brooks
Current Opinion in Rheumatology|May 1, 1995
Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamineP G Conaghan, P Brooks
Scandinavian Journal of Rheumatology|August 29, 2025
Understanding the use of thermography and its ability to predict ultrasound-detected joint inflammation at the metacarpophalangeal joint in patients with rheumatoid arthritisY K Tan, P G Conaghan
Current Opinion in Rheumatology|January 1, 1994
Rheumatic manifestations of malignancyP G Conaghan, P M Brooks
Drug Safety|October 1, 1994
Risks and benefits of drugs used in the management and prevention of goutP G Conaghan, R O Day
Arthritis and Rheumatism|June 12, 1999
Psoriatic arthritis: a unified concept twenty years onD McGonagle, P G Conaghan, P Emery
Pageof 14